Tilley W - Search Results

1

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.

Davies A, Nouruzi S, Ganguli D, Namekawa T, Thaper D, Linder S, Karaoğlanoğlu F, Omur ME, Kim S, Kobelev M, Kumar S, Sivak O, Bostock C, Bishop J, Hoogstraat M, Talal A, Stelloo S, van der Poel H, Bergman AM, Ahmed M, Fazli L, Huang H, Tilley W, Goodrich D, Feng FY, Gleave M, He HH, Hach F, Zwart W, Beltran H, Selth L, Zoubeidi A. Davies A, et al. Among authors: tilley w. Nat Cell Biol. 2021 Sep;23(9):1023-1034. doi: 10.1038/s41556-021-00743-5. Epub 2021 Sep 6. Nat Cell Biol. 2021. PMID: 34489572 Free PMC article.

2

Androgen receptors in prostate cancer.

Bentel JM, Tilley WD. Bentel JM, et al. Among authors: tilley wd. J Endocrinol. 1996 Oct;151(1):1-11. doi: 10.1677/joe.0.1510001. J Endocrinol. 1996. PMID: 8943763 Review. No abstract available.

3

Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers.

Zhang SX, Bentel JM, Ricciardelli C, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD. Zhang SX, et al. Among authors: tilley wd. J Urol. 1998 Feb;159(2):548-54. doi: 10.1016/s0022-5347(01)63981-8. J Urol. 1998. PMID: 9649289

4

Role of the androgen receptor in human breast cancer.

Birrell SN, Hall RE, Tilley WD. Birrell SN, et al. Among authors: tilley wd. J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):95-103. doi: 10.1023/a:1018730519839. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819508 Review.

5

Collocation of androgen receptor gene mutations in prostate cancer.

Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD. Buchanan G, et al. Among authors: tilley wd. Clin Cancer Res. 2001 May;7(5):1273-81. Clin Cancer Res. 2001. PMID: 11350894

6

Contribution of the androgen receptor to prostate cancer predisposition and progression.

Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Buchanan G, et al. Among authors: tilley wd. Cancer Metastasis Rev. 2001;20(3-4):207-23. doi: 10.1023/a:1015531326689. Cancer Metastasis Rev. 2001. PMID: 12085963 Review.

7

PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer.

Buchanan G, Craft PS, Yang M, Cheong A, Prescott J, Jia L, Coetzee GA, Tilley WD. Buchanan G, et al. Prostate. 2004 Sep 1;60(4):352-66. doi: 10.1002/pros.20079. Prostate. 2004. PMID: 15264248

8

Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.

Ricciardelli C, Choong CS, Buchanan G, Vivekanandan S, Neufing P, Stahl J, Marshall VR, Horsfall DJ, Tilley WD. Ricciardelli C, et al. Prostate. 2005 Apr 1;63(1):19-28. doi: 10.1002/pros.20154. Prostate. 2005. PMID: 15378523

9

Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant.

Butler LM, Centenera MM, Neufing PJ, Buchanan G, Choong CS, Ricciardelli C, Saint K, Lee M, Ochnik A, Yang M, Brown MP, Tilley WD. Butler LM, et al. Mol Endocrinol. 2006 May;20(5):1009-24. doi: 10.1210/me.2004-0401. Epub 2006 Jan 19. Mol Endocrinol. 2006. PMID: 16423882

10

Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.

Marrocco DL, Tilley WD, Bianco-Miotto T, Evdokiou A, Scher HI, Rifkind RA, Marks PA, Richon VM, Butler LM. Marrocco DL, et al. Mol Cancer Ther. 2007 Jan;6(1):51-60. doi: 10.1158/1535-7163.MCT-06-0144. Epub 2007 Jan 11. Mol Cancer Ther. 2007. PMID: 17218635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page